Per review of the literature, 48 pulmonary MEC tumors were tested for EGFR mutations, and nine tumors (19%) tested positive for mutations including two reports of L858R mutations, five L861Q mutations, one I760I mutation, and one exon 19 deletion. Here, EGFR is linked to mucoepidermoid carcinoma.